Status:
RECRUITING
Fake Carbs Practice With AID System - MiniMed 780G in Children and Adolescents With T1D.
Lead Sponsor:
Maria Chatzipsalti
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
7-19 years
Brief Summary
Hybrid Closed Loop (HCL) systems, such as the MiniMed 780G, have significantly improved glycemic outcomes in Type 1 Diabetes (T1D) management. The MiniMed 780G, an Advanced Hybrid Closed Loop (AHCL) s...
Detailed Description
Aim of the Study To compare glycemic control outcomes in individuals with T1D using the MiniMed™ 780G system during periods when 'fake carbohydrates' are used versus periods when this strategy is not ...
Eligibility Criteria
Inclusion
- Participants aged 7-18 years
- T1D \>6 months
- on MiniMed 780G system in automode.
Exclusion
- Participants with significant diabetes complications
- Participants with severe episode of diabetic ketoacidosis in the last 6 months
- Participants with hypoglycemia in the last 6 months.
Key Trial Info
Start Date :
June 4 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07179471
Start Date
June 4 2025
End Date
December 30 2025
Last Update
September 17 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Athens General Children's Hospital "Pan. & Aglaia Kyriakou"
Athens, Attica, Greece, 11527
2
Athens, Attiki
Athens, Attica, Greece, 11527
3
Diabetes Center
Athens, Attica, Greece, 11527